[1] |
de Benedictis FM, Carloni I. Management of necrotizing pneumonia in children: Time for a patient-oriented approach[J]. Pediatr Pulmonol, 2019, 54(9): 1351-1353.
doi: 10.1002/ppul.v54.9
|
[2] |
戴菱蔓. 儿童坏死性肺炎的研究进展[J]. 国际儿科学杂志, 2021, 48(3): 163-167.
|
[3] |
周云连, 刘金荣, 易秋维, 等. 儿童坏死性肺炎病原学的多中心回顾性研究[J]. 中华儿科杂志, 2021, 59(8): 658-664.
|
[4] |
中华人民共和国国家健康委员会, 国家中医药局. 儿童社区获得性肺炎诊疗规范(2019年版)[J]. 中华临床感染病杂志, 2019, 12(1): 6-13.
|
[5] |
郑英兰. 儿童细菌性与支原体肺炎坏死性肺炎的临床及CT影像学表现分析[D]. 重庆: 重庆医科大学, 2022.
|
[6] |
Zheng B, Zhao J, Cao L. The clinical characteristics and risk factors for necrotizing pneumonia caused by Mycoplasma pneumoniae in children[J]. BMC Infect Dis, 2020, 20(1): 391.
doi: 10.1186/s12879-020-05110-7
|
[7] |
Sawicki GS, Lu FL, Valim C, et al. Necrotising pneumonia is an increasingly detected complication of pneumonia in children[J]. Eur Respir J, 2008, 31(6): 1285-1291.
doi: 10.1183/09031936.00099807
pmid: 18216055
|
[8] |
张园园, 戴菱蔓, 周云连, 等. 儿童细菌性坏死性肺炎与肺炎支原体坏死性肺炎临床特征及预后比较[J]. 中华儿科杂志, 2019, 57(8): 625-630.
|
[9] |
卓裕霏, 刘金荣, 李惠民, 等. 肺炎支原体坏死性肺炎特征和预测因素分析[J]. 中国实用儿科杂志, 2020, 35(12): 973-976.
|
[10] |
Neeser OL, Vukajlovic T, Felder L, et al. A high C-reactive protein/procalcitonin ratio predicts Mycoplasma pneumoniae infection[J]. Clin Chem Lab Med, 2019, 57(10): 1638-1646.
doi: 10.1515/cclm-2019-0194
|
[11] |
Ness-Cochinwala M, Kobaitri K, Totapally BR. Characteristics and outcomes of children with necrotizing pneumonia[J]. Pediatr Crit Care Med, 2021, 22(12): e640-e643.
doi: 10.1097/PCC.0000000000002793
|
[12] |
黄倩, 曾赛珍, 陈玲玲, 等. 36例儿童坏死性肺炎临床特征分析[J]. 中国小儿急救医学, 2023, 30(2): 115-121.
|
[13] |
谭静, 李竹霞, 雷银兰, 等. 儿童肺脓肿94例临床分析[J]. 临床儿科杂志, 2020, 38(10): 730-735.
|
[14] |
胡亚美, 江载芳, 申昆玲, 等. 诸福棠实用儿科学[M]. 8 版. 北京人民卫生出版社, 1828-1829.
|
[15] |
王敏敏, 严永东. 儿童坏死性肺炎诊治进展[J]. 国际儿科学杂志, 2021, 48(8): 529-533
|
[16] |
Cha SI, Shin KM, Jeon KN, et al. Clinical relevance and characteristics of pleural effusion in patients with Mycoplasma pneumoniae pneumonia[J]. Scand J Infect Dis, 2012, 44(10): 793-797.
doi: 10.3109/00365548.2012.681696
|
[17] |
Tanaka H. Correlation between radiological and pathological findings in patients with Mycoplasma pneumoniae pneumonia[J]. Front Microbiol, 2016, 7: 695.
|
[18] |
刘金荣, 徐保平, 李惠民, 等. 肺炎链球菌坏死性肺炎20例诊治分析[J]. 中华儿科杂志, 2012, 50(6): 431-434.
|
[19] |
刘娜, 马静, 孟晨, 等. 肺炎支原体感染引起儿童心脏栓塞10例临床分析[J]. 中华实用儿科临床杂志, 2021, 36(16): 1253-1256.
|
[20] |
Yang B, Zhang W, Gu W, et al. Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children[J]. BMC Infect Dis, 2021, 21(1): 797.
doi: 10.1186/s12879-021-06469-x
|
[21] |
Sun LL, Ye C, Zhou YL, et al. Meta-analysis of the clinical efficacy and safety of high- and low-dose methylprednisolone in the treatment of children with severe Mycoplasma Pneumoniae pneumonia[J]. Pediatr Infect Dis J, 2020, 39(3): 177-183.
doi: 10.1097/INF.0000000000002529
|